Medtronic Builds Surgical Device Offerings Via Salient, Peak Acquisitions
This article was originally published in The Gray Sheet
Medtronic will expand its energy-based surgical equipment offerings through its purchase of privately-held Salient Surgical Technologies and Peak Surgical under separate agreements valued at a combined $645 million, announced July 7.
You may also be interested in...
Executives focused on new developments in the company’s ICD, spine, neuromodulation, and diabetes product lines, which have each faced particular challenges over the past year, during Medtronic’s second-quarter fiscal 2014 earnings call.
New CEOs at Vapotherm, Accelr8 and DiaGenic ASA.
Medtronic’s new vessel sealer, Quest’s brain infection test gain FDA market go-ahead.